(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 6.53%20.14B | 25.42%6.98B | 8.63%50.24B | 12.06%29.32B | 14.52%18.91B | -12.83%5.56B | -8.85%46.25B | -22.02%26.16B | -8.67%16.51B | -8.26%6.38B |
Operating income | 6.53%20.14B | 25.42%6.98B | 8.63%50.24B | 12.06%29.32B | 14.52%18.91B | -12.83%5.56B | -8.85%46.25B | -22.02%26.16B | -8.67%16.51B | -8.26%6.38B |
Cost of sales | 0.27%-16.45B | ---- | -9.49%-41.84B | ---- | -32.69%-16.49B | ---- | 2.69%-38.22B | ---- | 4.04%-12.43B | ---- |
Operating expenses | 0.27%-16.45B | -23.94%-5.16B | -9.49%-41.84B | -19.45%-24.16B | -32.69%-16.49B | 11.31%-4.16B | 2.69%-38.22B | 18.21%-20.23B | 4.04%-12.43B | 4.17%-4.69B |
Gross profit | 52.95%3.69B | 29.81%1.82B | 4.54%8.4B | -13.13%5.16B | -40.82%2.42B | -17.03%1.4B | -29.96%8.04B | -32.70%5.93B | -20.38%4.08B | -17.96%1.69B |
Selling expenses | -7.41%-604.81M | -1.82%-476.71M | 0.89%-3.16B | -4.49%-2.01B | 61.19%-563.08M | 3.53%-468.19M | -0.62%-3.19B | 30.83%-1.92B | 5.20%-1.45B | -4.09%-485.3M |
Administrative expenses | -14.47%-1.81B | 3.37%-382.5M | -9.50%-4.08B | 3.19%-1.38B | -6.81%-1.58B | -3.72%-395.84M | -5.55%-3.73B | -9.50%-1.43B | -0.36%-1.48B | 0.41%-381.65M |
Research and development expenses | ---- | -0.66%-368.36M | ---- | -46.70%-1.04B | ---- | -24.69%-365.95M | ---- | 14.30%-706.94M | ---- | -19.98%-293.48M |
Profit from asset sales | ---- | -68.79%-4.42M | ---- | -12,298.99%-61.76M | ---- | -5.33%-2.62M | ---- | -142.73%-498.13K | ---- | -41.44%-2.49M |
Revaluation surplus | ---- | -146.00%-95.47M | ---- | 196.74%234.9M | ---- | 181.11%207.55M | ---- | -473.87%-242.81M | ---- | -1,120.01%-255.89M |
-Changes in the fair value of other assets | ---- | -146.00%-95.47M | ---- | 196.74%234.9M | ---- | 181.11%207.55M | ---- | -473.87%-242.81M | ---- | -1,120.01%-255.89M |
Impairment and provision | 28.90%-125.85M | 76.65%-7.93M | -213.59%-306.56M | -252.59%-225.9M | -244.99%-176.99M | -245.26%-33.96M | 138.14%269.88M | 122.70%148.05M | 209.60%122.07M | 164.29%23.38M |
-Other impairment is provision | 28.90%-125.85M | 76.65%-7.93M | -213.59%-306.56M | -252.59%-225.9M | -244.99%-176.99M | -245.26%-33.96M | 138.14%269.88M | 122.70%148.05M | 209.60%122.07M | 164.29%23.38M |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -21.17%-609.76M | --0 |
Special items of operating profit | -50.19%1.17B | -85.79%268.92M | 11.98%2.79B | 21.77%2.4B | 59.87%2.34B | 32.98%1.89B | 77.57%2.49B | 34.23%1.97B | 94.85%1.46B | 124.07%1.42B |
Operating profit | -4.73%2.32B | -67.34%719.03M | -6.14%3.64B | -18.58%2.95B | 14.49%2.44B | 30.54%2.2B | -10.14%3.88B | -22.08%3.62B | -5.77%2.13B | 8.22%1.69B |
Financing cost | 1.22%-617.72M | 38.70%-188.29M | -3.00%-1.37B | -10.20%-778.33M | ---625.33M | -255.72%-307.16M | ---1.33B | 21.98%-706.27M | ---- | 63.16%-86.35M |
Share of profits of associates | 0.73%22.35M | ---- | -95.01%10.1M | ---- | -74.83%22.18M | ---- | 2,092.75%202.24M | ---- | 171.26%88.12M | ---- |
Share of profit from joint venture company | -19.56%117.69M | ---- | 1,001.87%239.56M | ---- | 3.25%146.3M | ---- | -93.18%21.74M | ---- | -42.60%141.7M | ---- |
Special items of earning before tax | ---- | -59.03%-8.55M | ---- | -647.49%-38.36M | ---- | -485.70%-5.38M | ---- | 182.92%7.01M | ---- | -68.80%1.39M |
Earning before tax | -6.87%1.84B | -72.35%522.19M | -9.11%2.52B | -27.06%2.13B | -16.02%1.98B | 17.95%1.89B | -40.12%2.77B | -21.74%2.92B | -7.08%2.36B | 20.56%1.6B |
Tax | 35.68%-408.94M | 77.99%-135.55M | -197.70%-997.02M | -47.41%-761.69M | -64.07%-635.77M | -105.18%-615.75M | 60.49%-334.91M | 23.23%-516.72M | 10.48%-387.51M | -41.38%-300.1M |
After-tax profit from continuing operations | 6.74%1.44B | -69.63%386.64M | -37.53%1.52B | -43.06%1.37B | -31.77%1.35B | -2.17%1.27B | -35.55%2.44B | -21.41%2.4B | -6.38%1.97B | 16.60%1.3B |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Earning after tax | 6.74%1.44B | -69.63%386.64M | -37.53%1.52B | -43.06%1.37B | -31.77%1.35B | -2.17%1.27B | -35.55%2.44B | -21.41%2.4B | -6.38%1.97B | 16.60%1.3B |
Minority profit | -47.72%49.15M | 41.18%54.02M | 257.78%191.2M | 178.54%107.66M | 81.74%94.01M | 6.71%38.26M | 7.92%53.44M | -15.14%38.65M | -20.87%51.73M | 96.37%35.86M |
Profit attributable to shareholders | 10.83%1.39B | -73.06%332.62M | -44.16%1.33B | -46.69%1.26B | -34.82%1.25B | -2.42%1.23B | -36.12%2.38B | -21.51%2.36B | -5.92%1.92B | 15.27%1.27B |
Basic earnings per share | 14.29%0.32 | -74.62%0.0726 | -44.23%0.29 | -46.65%0.2786 | -36.36%0.28 | 0.28%0.286 | -38.82%0.52 | -24.19%0.5222 | -4.35%0.44 | 13.67%0.2852 |
Diluted earnings per share | 14.29%0.32 | -74.62%0.0726 | -44.23%0.29 | -46.65%0.2786 | -36.36%0.28 | 0.28%0.286 | -38.82%0.52 | -24.19%0.5222 | -4.35%0.44 | 13.67%0.2852 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) | -- | -- | -- | Deloitte & Touche Tohmatsu, Deloitte Touche Tohmatsu (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data